| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 126647-12-9 | | 2-oxo-1-pyrrolidineethanethioamid | | | | |
| 126647-14-1 | | n-(1-(dimethylamino)ethylidene)-2-thioxo-1-pyrrolidineethanethioamid | | | | |
| 126647-15-2 | | n-(1-methyl-2-pyrrolidinylidene)-2-thioxo-1-pyrrolidineethanethioamid | | | | |
| 126647-16-3 | | 1-pyrrolidineethanethioamide, n-(hexahydro-1-methyl-2h-azepin-2-ylidene)-2-thio | | | | |
| 126647-17-4 | | n-(1-methyl-2-pyrrolidinylidene)-2-oxo-1-pyrrolidineethanethioamid | | | | |
| 126647-18-5 | | acetic acid, cyano(1-(2-(((dimethylamino)methylene)amino)-2-oxoethyl)-2-pyrroli | | | | |
| 126648-96-2 | | proto-oncogene protein ski | | | | |
| 1266480-96-9 | 2,4-二溴-5-氯嘧啶 | 2,4-dibromo-5-chloropyrimidine | | | | |
| 1266484-49-4 | | 5-(4-methoxy-3-nitrophenyl)-1h-pyrazole-4-carboxylic acid | | | | |
| 12665-51-9 | | n-(2-bromopropyl)-n-ethyl-fluoren-9-amin hydrobromide | | | | |
| 126650-71-3 | | 2,4)triazino(3,4-a)phthalazine, 7-ethoxy-3-phenyl-4h-( | | | | |
| 126650-72-4 | | 2-propanol, 1-((3-(4-methoxyphenyl)-4h-(1,2,4)triazino(3,4-a)phthalazin-7-yl)me | | | | |
| 126650-73-5 | | 2,4)triazino(3,4-a)phthalazine, 3-phenyl-7-(1-pyrrolidinyl)-4h-( | | | | |
| 126650-79-1 | | 2,4)triazino(3,4-a)phthalazin-4-one, 3-methyl-7-(1-pyrrolidinyl)-4h-( | | | | |
| 126650-80-4 | | 4h-(1,2,4)triazino(3,4-a)phthalazin-4-one, 3-(4-methoxyphenyl)-7-(1-pyrrolidiny | | | | |
| 126650-81-5 | | 4h-(1,2,4)triazino(3,4-a)phthalazin-4-one, 7-((2-hydroxypropyl)methylamino)-3-( | | | | |
| 126651-70-5 | | ethyl (4-methyl-1-piperazinyl)carbothioylcarbamate | | | | |
| 126651-92-1 | | resorthiomycin | | | | |
| 1266522-92-2 | | methyl 3-oxopiperidine-4-carboxylate hydrochloride | | | | |
| 126653-00-7 | 1-哌嗪-1-异喹啉 | 1-piperazine-1-yl-isoquinoline | | | | |
| 126653-12-1 | | Bismuth copper strontium oxide(Bi4Cu5Sr8O19) | Bi4Cu5O19Sr8 | 2158.60 | | |
| 126653-41-6 | | 3-(3,4-dihydroxy-5-nitrophenyl)-benzo(g)quinoxalin-2(1h)-on | | | | |
| 126654-66-8 | | 3'-prenyl-4'-methoxyisoflavone-7-o-beta-(2''-o-4-coumaroyl)glucopyranoside | | | | |
| 1266549-31-8 | poly({4,8-bis[(2-ethylhexyl)oxy]benzo[1,2-b:4,5-b′]dithiophene-2,6-diyl}{3-fluoro-2-[(2-ethylhexyl)carbonyl]thieno[3,4-b]thiophenediyl}) | | | | | |
| 1266558-20-6 | 2-甲基-2h-吲唑-5-甲醛 | 2-methyl-2h-indazole-5-carbaldehyde | | | | |
| 126657-27-0 | | 14-quinaldinoyloxydaunorubicin | | | | |
| 126659-84-5 | | n-(4-methoxyphenyl)-2-oxo-1-pyrrolidinecarboxamid | | | | |
| 126659-86-7 | | n-(4-(dimethylamino)phenyl)-2-oxo-1-pyrrolidinecarboxamid monohydrochloride | | | | |
| 126659-87-8 | | n-(3,4-dimethoxyphenyl)-2-oxo-1-pyrrolidinecarboxamid | | | | |
| 126659-88-9 | | 2-oxo-n-(3,4,5-trimethoxyphenyl)-1-pyrrolidinecarboxamid | | | | |
| 126659-89-0 | | 2-oxo-n-(5,6,7,8-tetrahydro-1-naphthalenyl)-1-pyrrolidinecarboxamid | | | | |
| 126659-90-3 | | 2-oxo-n-4-pyridinyl-1-pyrrolidinecarboxamid | | | | |
| 126659-91-4 | | 2-oxo-n-2-thiazolyl-1-pyrrolidinecarboxamid | | | | |
| 126659-94-7 | | n-(4-methoxyphenyl)-3-methyl-2-oxo-1-pyrrolidinecarboxamid | | | | |
| 126659-95-8 | | n-(4-methoxyphenyl)-2-methyl-5-oxo-1-pyrrolidinecarboxamid | | | | |
| 126659-96-9 | | 2-(hydroxymethyl)-5-oxo-n-phenyl-1-pyrrolidinecarboxamid | | | | |
| 126660-48-8 | | df 10967 | | | | |
| 126661-24-3 | | 2-propanol, 1-(2-((4-(diethylamino)phenyl)ethynyl)phenoxy)-3-((1,1-dimethyl)eth | | | | |
| 126661-30-1 | | 2-propanol, 1-(2-((4-(dimethylamino)-3-methylphenyl)ethynyl)phenoxy)-3-((1,1-di | | | | |
| 126661-37-8 | | 2-propanol, 1-(2-((4-(dimethylamino)phenyl)ethynyl)-5-methoxyphenoxy)-3-((1,1-d | | | | |
| 126661-39-0 | | bpat-143 dihydriodide | | | | |
| 126661-83-4 | | cyclophellitol | | | | |
| 1266615-54-6 | 6-羟基-2,4,5-三氨基-嘧啶硫酸盐水合物 | 6-hydroxy-2,4,5-triaminopyrimidine sulfate hydrate | | | | |
| 1266615-59-1 | 吗啉乙磺酸 | 2-(4-morpholinyl)ethanesulfonic acid hydrate | | | | |
| 1266615-63-7 | | 3-amino-1h-1,2,4-triazole-5-carboxylic acid hydrate | | | | |
| 1266615-85-3 | 5,6-二苯基-3-(2-吡啶基)-1,2,4-三嗪-4,4-二磺酸单钠盐水合物 | | | | | |
| 1266616-11-8 | 缬沙坦杂质6 | valsartan impurity 6 | | | | |
| 126663-34-1 | | 2-ethanediyl), alpha-(carboxymethyl)- omega -(eicosenyloxy)-poly(oxy- sodium | | | | |
| 126663-35-2 | | poly(oxy-1,2-ethanediyl), alpha-(carboxymethyl)- omega -(hexadecenyloxy), sodiu | | | | |
| 126663-38-5 | | n-hydroxythalidomide | | | | |
m.cnreagent.com